Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors

Abstract : An efficient synthetic strategy able to modulate the structure of the tetrahydropyridine isoindolone (Valmerin) skeleton was developed. A library of more than 30 novel final structures was generated. Biological activities on CDK5 and GSK3 as well as cellular effects on cancer cell lines were measured for each novel compound. Additionally to support the SAR, a docking study was performed. A potent GSK3/CDK5 dual inhibitor (37, IC50 CDK5/GSK3 35/7 nM) was obtained. Best antiproliferative effects were obtained on lung and prostate cell lines with IC50 = 20 nM
Document type :
Journal articles
Liste complète des métadonnées
Contributor : Laurent Jonchère <>
Submitted on : Thursday, March 31, 2016 - 2:16:11 PM
Last modification on : Tuesday, April 2, 2019 - 3:30:25 AM



Aziz Ouach, Rajâa Boulahjar, Christine Vala, Stéphane Bourg, Pascal Bonnet, et al.. Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors. European Journal of Medicinal Chemistry, Elsevier, 2016, 115, pp.311--325. ⟨10.1016/j.ejmech.2016.02.072⟩. ⟨hal-01295635⟩



Record views